Melatonin supplements market to reach $4.89 billion by 2030 at 12.2% CAGR, driven by rising prevalence of sleep disorders.
Read MoreMelanoma Therapeutics Market Performance Outlook 2026–2030: Revenue to Hit $7.49 Billion at 11% CAGR
Melanoma therapeutics market to reach $7.49 billion by 2030 at 11.0% CAGR, driven by increasing incidence of melanoma.
Read MoreMelanoma drugs market to reach $17.07 billion by 2030 at 11.1% CAGR, driven by increase in the incidence of melanoma in males.
Read MoreMeganuclease genome editing market to reach $2.69 billion by 2030 at 16.9% CAGR, driven by increasing prevalence of genetic diseases.
Read MoreMedulloblastoma drug market to reach $4.49 billion by 2030 at 8.2% CAGR, driven by rising incidence of brain tumors, increasing healthcare expenditure, and growing focus on personalized medicine.
Read MoreMeditation software market to reach $7.65 billion by 2030 at 11.2% CAGR, driven by growing awareness about stress-related issues.
Read MoreThe global medicinal mushroom market to reach $66.63 billion by 2030 at 9.6% CAGR, driven by growing vegan population.
Read MoreMedicated skincare market to reach $55.64 billion by 2030 at 6.5% CAGR, driven by rising prevalence of skin disorders.
Read MoreMedical marijuana market to reach $106.49 billion by 2030 at 22.0% CAGR, driven by increasing prevalence of cancer.
Read MoreThe global medical foods market to reach $35.42 billion by 2030 at 7.8% CAGR, driven by increase in the geriatric population.
Read More